COVID-19 Launches Retinal Telemedicine into the Next Frontier

Semin Ophthalmol. 2021 Mar 2:1-6. doi: 10.1080/08820538.2021.1893352. Online ahead of print.

ABSTRACT

INTRODUCTION: Telemedicine in ophthalmology, and specifically in retinal diseases, has made significant advancements in recent years. The COVID-19 pandemic has launched telehealth into a new era by creating demand from patients and physicians alike, while breaking down previous insurance, reimbursement, access and educational barriers.

METHODS: This paper reviews mulitple studies demonstrating the use of telemedicine in managing various retinal conditions before and during the COVID-19 pandemic.

CONCLUSION: Moving forward, promising new devices and models of care ensure that tele-retinal care will continue to expand and become a vital part of how we screen, diagnose and monitor retinal diseases.

PMID:33651652 | DOI:10.1080/08820538.2021.1893352